Bumetanide
NDC 69238-1489, Bumetanide, tablet, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-1489
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209724
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1489 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUMETANIDE.5 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-1489-1 | 69238148901 | 100 TABLET in 1 BOTTLE (69238-1489-1) |
| 69238-1489-5 | 69238148905 | 500 TABLET in 1 BOTTLE (69238-1489-5) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9188ab17-8539-48a5-905f-ad35ab5a0b93NADAC price for package 69238148901
GET /v1/drugs/nadac/69238148901
Use it
Look up 69238-1489 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1489 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-1489. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.